Anti-CADM-140/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease

• SATO Shinji

  Division of Rheumatology, Department of Internal Medicine, Tokai University School of Medicine

• KUWANA Masataka

  Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine

• FUJITA Takashi

  Laboratory of Molecular Genetics, Institute for Virus Research Kyoto University

• SUZUKI Yasuo

  Division of Rheumatology, Department of Internal Medicine, Tokai University School of Medicine

Journal

• Modern rheumatology

  Modern rheumatology 23 (3), 496-502, 2013-05-01

Keywords

• Anti-CADM-140 autoantibody
• Anti-MDA5 autoantibody
• Clinically amyopathic dermatomyositis (CADM)
• Dermatomyositis (DM)
• Rapidly progressive interstitial lung disease (RP-ILD)

Details

• CRID: 1570291226219163008
• NII Article ID: 10031175908
• NII Book ID: AA1157187X
• ISSN: 14397595
• Web Site: https://search.jamas.or.jp/link/ui/2014145436
• Text Lang: en
• Data Source:
  • CiNii Articles